Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study
Authors:
- Ulrich PreussUPUlrich Preuss
- Stephen J. RalstonSRStephen J. Ralston
- David CoghillDCDavid Coghill
- ADORE Study Group*AGADORE Study Group*
- 1 December 2006
- journal article
- research article
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 15 (S1) , i4-i14
Abstract
To describe the methodology and to present the baseline findings of the Attention-deficit/hyperactivity Disorder Observational Research in Europe (ADORE) study, the primary objective of which is to describe the relationship between treatment regimen prescribed and quality of life of children with ADHD in actual practice.Keywords
This publication has 40 references indexed in Scilit:
- The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHDEuropean Child & Adolescent Psychiatry, 2006
- Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child EditionEuropean Child & Adolescent Psychiatry, 2006
- Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European studyEuropean Child & Adolescent Psychiatry, 2006
- Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European studyEuropean Child & Adolescent Psychiatry, 2006
- Co-existing psychiatric problems in ADHD in the ADORE cohortEuropean Child & Adolescent Psychiatry, 2006
- Risk factors for the development of emotional and behavioural problems in children born to drug-dependent mothersEuropean Child & Adolescent Psychiatry, 2006
- Children in foster care: Mental health, service use and costsEuropean Child & Adolescent Psychiatry, 2006
- ADORE ? Attention?Deficit Hyperactivity Disorder Observational Research in EuropeEuropean Child & Adolescent Psychiatry, 2004
- European clinical guidelines for hyperkinetic disorder ? first upgradeEuropean Child & Adolescent Psychiatry, 2004
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002